Microplate assays for in vitro evaluation of anti-Pneumocystis drugs.

Suppr

超能文献

作者信息

Herreros E, Almela M J, Martinez M, Lozano S, Jackson H, Aliouat E M, Gargallo-Viola D

机构信息

Glaxo Wellcome S.A., Madrid, Spain.

出版信息

J Eukaryot Microbiol. 1997 Nov-Dec;44(6):43S-44S. doi: 10.1111/j.1550-7408.1997.tb05766.x.

DOI:10.1111/j.1550-7408.1997.tb05766.x

PMID:9508430

Abstract

摘要

相似文献

Microplate assays for in vitro evaluation of anti-Pneumocystis drugs.

J Eukaryot Microbiol. 1997 Nov-Dec;44(6):43S-44S. doi: 10.1111/j.1550-7408.1997.tb05766.x.

Evaluation of anti-Pneumocystis agents using flow cytometry.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):105S-106S.

Algorithmic analysis of in vitro chemotherapy against Pneumocystis carinii.

J Eukaryot Microbiol. 1997 Nov-Dec;44(6):30S. doi: 10.1111/j.1550-7408.1997.tb05754.x.

Measurement of protein biosynthesis in Pneumocystis carinii to investigate the effects of translation-specific inhibitors.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):76S-78S.

A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents.一种用于评估候选抗卡氏肺孢子虫药物的细胞毒性测定法。

Antimicrob Agents Chemother. 1997 Feb;41(2):379-84. doi: 10.1128/AAC.41.2.379.

Standardization of an in vitro drug screening assay by use of cryopreserved and characterized Pneumocystis carinii populations.利用冷冻保存并经鉴定的卡氏肺孢子虫群体对体外药物筛选试验进行标准化。

J Eukaryot Microbiol. 2001;Suppl:178S-179S. doi: 10.1111/j.1550-7408.2001.tb00509.x.

In vitro drug assays and statistical analysis.

FEMS Immunol Med Microbiol. 1998 Sep;22(1-2):181-3. doi: 10.1111/j.1574-695X.1998.tb01204.x.

Sodium transport inhibitors decrease proliferation of Pneumocystis carinii in short-term culture.钠转运抑制剂在短期培养中可降低卡氏肺孢子虫的增殖。

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):110S.

Effects of sterol inhibitors on the ATP content of Pneumocystis carinii.固醇抑制剂对卡氏肺孢子虫ATP含量的影响。

J Eukaryot Microbiol. 1999 Sep-Oct;46(5):142S-143S.

Yeast glucan of Pneumocystis carinii cyst wall: an excellent target for chemotherapy.卡氏肺孢子虫囊肿壁的酵母聚糖：化疗的绝佳靶点。

J Protozool. 1991 Nov-Dec;38(6):6S-7S.

引用本文的文献

SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.SYTO-13，一种作为监测抗肺孢子菌药物体外药效学参数新工具的活力标记物。

PLoS One. 2015 Jun 23;10(6):e0130358. doi: 10.1371/journal.pone.0130358. eCollection 2015.

Antifungal activities and cytotoxicity studies of six new azasordarins.六种新型氮杂索德菌素的抗真菌活性及细胞毒性研究

Antimicrob Agents Chemother. 2001 Nov;45(11):3132-9. doi: 10.1128/AAC.45.11.3132-3139.2001.

In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.与市售化合物相比，索达菌素衍生物对从大鼠分离出的卡氏肺孢子虫的体外药效学参数。

Antimicrob Agents Chemother. 2000 May;44(5):1284-90. doi: 10.1128/AAC.44.5.1284-1290.2000.

Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.索德菌素：新型抗真菌衍生物对致病性酵母、卡氏肺孢子虫和丝状真菌的体外活性

Antimicrob Agents Chemother. 1998 Nov;42(11):2863-9. doi: 10.1128/AAC.42.11.2863.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验